4 Works

Reactions of Hydrazones and Hydrazides with Lewis Acidic Boranes - data

Theodore A Gazis, Ayan Dasgupta, Michael S Hill, Jeremy M Rawson, Thomas Wirth & Rebecca L Melen
The reaction of (diphenylmethylene)hydrazone or 1,4-bis-hydraQ4 zone-ylidene(phenyl)methyl)benzene with Lewis acidic boranes B(2,4,6-F3C6H2)3 or B(3,4,5-F3C6H2)3 generates the Lewis acid– base adducts. Alternatively, when (9H-fluoren-9-ylidene)hydrazone is employed then several products were isolated including 1,2-di(9H-fluoren-9-ylidene)hydrazone, the 2 : 1 borane adduct of NH2–NH2 and the 1-(diarylboraneyl)-2-(9H-fluoren-9-ylidene) hydrazone in which one ArH group has been eliminated. The benzhydrazide starting material also initially gives an adduct when reacted with Lewis acidic boranes which upon heating eliminates ArH generating a CON2B...

Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting

Katherine Rudzinski, Soo Chan Carusone, Andre Ceranto, Francisco Ibáñez-Carrasco, Lisa McDonald, Dean Valentine, Adrian Guta, Elaine Hyshka, William O’Leary, Andra Cardow & Carol Strike
Abstract Background Hospital-based harm reduction services are needed to reduce drug-related harms, facilitate retention in care, and increase medical treatment adherence for people who use drugs. Philanthropic donor support plays a key role in delivering such innovative services which might fall outside current funding streams. However, little is known about how the principles, implementation, and practice of harm reduction services, which are often highly stigmatized, may impact donor behaviours. We explored this issue within Casey...

Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting

Katherine Rudzinski, Soo Chan Carusone, Andre Ceranto, Francisco Ibáñez-Carrasco, Lisa McDonald, Dean Valentine, Adrian Guta, Elaine Hyshka, William O’Leary, Andra Cardow & Carol Strike
Abstract Background Hospital-based harm reduction services are needed to reduce drug-related harms, facilitate retention in care, and increase medical treatment adherence for people who use drugs. Philanthropic donor support plays a key role in delivering such innovative services which might fall outside current funding streams. However, little is known about how the principles, implementation, and practice of harm reduction services, which are often highly stigmatized, may impact donor behaviours. We explored this issue within Casey...

Lewis Acid Assisted Brønsted Acid Catalysed Decarbonylation of Isocyanates: A Combined DFT and Experimental Study - data

Ayan Dasgupta, Yara Van Ingen, Michael G Guerzoni, Kaveh Farshadfar, Jeremy Rawson, Emma Richards, Alireza Ariafard & Rebecca Melen
An efficient and mild reaction protocol for the decarbonylation of isocyanates has been developed using catalytic amounts of Lewis acidic boranes. Detailed DFT studies were undertaken to account for the formation of the mono/di-carboxamidation products and benzoxazolone compounds. The dataset includes compound characterisation data for the compounds synthesised in this work.

Registration Year

  • 2022
    3
  • 2020
    1

Resource Types

  • Collection
    4

Affiliations

  • University of Windsor
    4
  • Casey House
    2
  • Wilfrid Laurier University
    2
  • Royal Alexandra Hospital
    2
  • University of Alberta
    2
  • McMaster University
    2
  • University of Toronto
    2
  • Cardiff University
    2
  • St. Michael's Hospital
    2
  • University of Bath
    1